PIC
Portland Investment Counsel Portfolio holdings
AUM
$340M
1-Year Return
50.8%
This Quarter Return
-5.59%
1 Year Return
+50.8%
3 Year Return
+61.43%
5 Year Return
+85.27%
10 Year Return
–
AUM
$218M
AUM Growth
+$15.3M
(+7.5%)
Cap. Flow
+$26.8M
Cap. Flow
% of AUM
12.34%
Top 10 Holdings %
Top 10 Hldgs %
84.44%
Holding
41
New
5
Increased
8
Reduced
5
Closed
3
Top Buys
| 1 |
Canadian Imperial Bank of Commerce
CM
|
$15.5M |
| 2 |
Verizon
VZ
|
$13.4M |
| 3 |
Royal Bank of Canada
RY
|
$2.1M |
| 4 |
Bank of Montreal
BMO
|
$781K |
| 5 |
Vodafone
VOD
|
$722K |
Top Sells
| 1 |
Nomad Foods
NOMD
|
$2.59M |
| 2 |
Liberty Latin America Class C
LILAK
|
$1.31M |
| 3 |
Citigroup
C
|
$905K |
| 4 |
Goldman Sachs
GS
|
$748K |
| 5 |
Perspective Therapeutics
CATX
|
$683K |
Sector Composition
| 1 | Financials | 72.14% |
| 2 | Communication Services | 18.98% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 1.19% |
| 5 | Energy | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
RadNet
RDNT
$5.56B
| $691K | 0.32% |
24,500
| – | – |
|
|
27
Nomad Foods
NOMD
$2.24B
| $662K | 0.3% |
43,500
-170,078
| -80% | -$2.59M |
|
|
28
Liberty Latin America Class C
LILAK
$1.63B
| $591K | 0.27% |
72,478
-160,096
| -69% | -$1.31M |
|
29
Altice USA
ATUS
$1.09B
| $553K | 0.25% |
169,170
| – | – |
|
30
Mastercard
MA
$538B
| $551K | 0.25% |
1,391
| – | – |
|
31
AT&T
T
$212B
| $293K | 0.13% |
19,500
+4,500
| +30% | +$67.6K |
|
32
Regeneron Pharmaceuticals
REGN
$60.1B
| $269K | 0.12% |
327
-3
| -0.9% | -$2.47K |
|
33
National Grid
NGG
$68.4B
| $200K | 0.09% |
+3,452
| New | +$200K |
|
|
PNT
34
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $133K | 0.06% |
20,000
-93,300
| -82% | -$620K |
|
35
Plug Power
PLUG
$1.66B
| $91K | 0.04% |
+12,000
| New | +$91K |
|
36
NuScale Power
SMR
$4.82B
| $74K | 0.03% |
+15,000
| New | +$74K |
|
37
Iovance Biotherapeutics
IOVA
$796M
| $68K | 0.03% |
+15,000
| New | +$68K |
|
38
Lumen
LUMN
$5.1B
| $27K | 0.01% |
19,000
| – | – |
|
|
39
Perspective Therapeutics
CATX
$263M
| – | – |
-103,410
| Closed | -$683K |
|
|
40
Goldman Sachs
GS
$227B
| – | – |
-2,320
| Closed | -$748K |
|
|
BKI
41
DELISTED
Black Knight, Inc. Common Stock
BKI
| – | – |
-7,315
| Closed | -$437K |
|